Abstract:
A method for real-time measurement of a dose of radiological radiation absorbed by a region to be inspected and which is subjected to a flow of radiological radiation. Said method comprises the following steps consisting in (a) detecting the incident radiation (11) incident at at least one point of the region to be inspected with the aid of at least one first measuring fiber optic beam (2) containing at least one fiber placed in said region to be inspected and adapted in such a way that it can generate a light signal when it receives radiological radiation; 2) measuring said light signal outside the region to be inspected after transmission along the measuring fiber optic; and (c) determining the dose of radiological radiation received by said measuring fiber optic from the light signal.
Abstract:
The present invention relates to a valve device (1) designed to be implanted in a dysfunctional larynx or in a prosthetic larynx, said device comprising a distal portion forming an annular support structure (3, 3', 3'') and a central portion forming an obturator (5, 5'), characterized in that said obturator (5, 5') comprises i) a peripheral part forming a first valve (7, 7', 7'') integral with the annular support structure (3, 3', 3'') in a first hinge region (2, 2''), and ii) a central part forming a second valve (9, 9', 9'') integral with the first valve in a second hinge region (4, 4'').
Abstract:
The invention concerns the use of a PTHrP antagonist for preparing a pharmaceutical composition for treating renal cell carcinoma (RCC) in a mammal and in particular in a human subject. Advantageously, the invention is of particular interest for inhibiting or reducing tumor growth and/or metastasis formation in kidney cancer and its metastatic developments, in particular in the lung and the liver.